Citation Impact

Citing Papers

Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Immune Cells in Hyperprogressive Disease under Immune Checkpoint-Based Immunotherapy
2022

Works of Xin Ba being referenced

Hyperprogressive Disease in Cancers Treated With Immune Checkpoint Inhibitors
2021
Rankless by CCL
2026